On September 14, 2025, at the China International Fair for Trade in Services held in Shougang Park, Beijing, Park Heng Bomai and the Future Biotechnology Research Institute of Zhongke officially signed a strategic cooperation agreement to jointly carry out the National Health Commission's "Medical Prevention Integration Research Project". This project aims to provide big data support for the establishment of a standardized biological treatment system in China through the large-scale clinical application research of our company's new generation regenerative therapy technology in the field of orthopedics.
About Park Heng
Park Heng Bomai is an innovative enterprise specializing in the application of new in vitro 3D culture technology in regenerative medicine and preclinical drug research and development. Its newly developed self-assembled in vitro 3D culture technology (NAC Organ technology) based on nano nucleic acid material technology has advantages such as high modeling efficiency, high flux, good repeatability, and good reproducibility. The preclinical drug detection platform developed using NAC Organ technology has established dozens of chronic disease, tumor, physiological organ, and multi organ composite models, as well as a complete drug evaluation system, serving well-known pharmaceutical companies and clinical institutions at home and abroad, and has been highly recognized by the industry.
